###begin article-title 0
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(COL29A1)</italic>
Variants in a Novel Epidermal Collagen Gene (COL29A1) Are Associated with Atopic Dermatitis
###end article-title 0
###begin p 1
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 858 866 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1,</italic>
###xml 909 916 909 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1109 1116 1109 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1157 1165 <span type="species:ncbi:9606">patients</span>
Atopic dermatitis (AD) is a common chronic inflammatory skin disorder and a major manifestation of allergic disease. AD typically presents in early childhood often preceding the onset of an allergic airway disease, such as asthma or hay fever. We previously mapped a susceptibility locus for AD on Chromosome 3q21. To identify the underlying disease gene, we used a dense map of microsatellite markers and single nucleotide polymorphisms, and we detected association with AD. In concordance with the linkage results, we found a maternal transmission pattern. Furthermore, we demonstrated that the same families contribute to linkage and association. We replicated the association and the maternal effect in a large independent family cohort. A common haplotype showed strong association with AD (p = 0.000059). The associated region contained a single gene, COL29A1, which encodes a novel epidermal collagen. COL29A1 shows a specific gene expression pattern with the highest transcript levels in skin, lung, and the gastrointestinal tract, which are the major sites of allergic disease manifestation. Lack of COL29A1 expression in the outer epidermis of AD patients points to a role of collagen XXIX in epidermal integrity and function, the breakdown of which is a clinical hallmark of AD.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 808 816 808 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1,</italic>
###xml 886 893 886 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1023 1030 1023 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 872 880 <span type="species:ncbi:9606">patients</span>
Atopic dermatitis (AD, eczema) is a common chronic inflammatory skin disorder and a major manifestation of allergic disease. Typically, AD first occurs in early childhood, often preceding the onset of allergic airways disease, such as asthma and hay fever. A family history of allergic disorders is the single strongest predictor for AD, showing that genetic factors play a major role in the disease development. We have previously mapped a disease locus for AD on Chromosome 3q21, Now we have used a dense map of microsatellite markers and single nucleotide polymorphisms (SNPs) to find the underlying disease gene. We identified genetic markers in a subregion that showed association with AD, and replicated this finding in a large independent family cohort. The associated region contained a single gene, COL29A1, which encodes a novel collagen. We demonstrate that AD patients lack COL29A1 expression in the outer epidermis, implicating collagen XXIX in epidermal integrity and function. The gene expression pattern of COL29A1 in other organs, including the lung and the gut, suggests that this gene could have a role in a wider spectrum of allergic diseases and may provide a molecular link between AD and respiratory airways disease and food allergies.
###end p 4
###begin p 5
###xml 193 201 <span type="species:ncbi:9606">patients</span>
The gene underlying atopic dermatitis susceptibility has been identified by gene mapping as expressing a novel collagen, whose expression is lacking in the outer epidermis of atopic dermatitis patients.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b001">1</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b002">2</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b003">3</xref>
###xml 197 205 <span type="species:ncbi:9606">children</span>
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is characterized by intensely itchy skin lesions. AD is one of the most common chronic diseases in childhood affecting 10%-20% of children in industrialized societies [1], with a steady increase over the past decades [2,3]. Along with asthma and hay fever, AD is commonly associated with an abnormal immune response and the formation of allergy antibodies (IgE) against innocuous environmental allergens.
###end p 7
###begin p 8
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b004">4</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b005">5</xref>
###xml 178 186 <span type="species:ncbi:9606">children</span>
###xml 245 250 <span type="species:ncbi:9606">child</span>
###xml 422 428 <span type="species:ncbi:9606">infant</span>
AD is often the first clinical manifestation of allergic disease. The onset of disease is typically observed during the first two years of life [4]. For the majority of affected children, AD heralds a lifetime of allergic disease. A susceptible child commonly passes a characteristic sequence of transient or persistent disease stages that is known as the "atopic march" which begins with AD and food allergy in the young infant and continues with the development of allergic airways disease later in childhood and adulthood [5]. The close familial and intra-individual association of the allergic disorder strongly suggests shared genetic etiology.
###end p 8
###begin p 9
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b006">6</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b007">7</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b008">8</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b009">9</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b010">10</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b011">11</xref>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 785 793 <span type="species:ncbi:9606">children</span>
A strong genetic component in allergic disorders has been recognized almost a century ago. Cooke and van der Veer first reported that the relatives of patients are at significantly increased risk of developing allergic disease [6]. Even today, a positive family history for allergic disorders is the single strongest predictor for the development of AD [7]. Additional evidence for the importance of genetic factors in atopic disease comes from twin studies. The concordance rate for AD among monozygotic twins of about 80% far exceeds the concordance rate of 20% observed among dizygotic twins [8,9]. These data clearly indicate that the genetic contribution to the expression of AD is substantial. Furthermore, studies on the vertical transmission of AD and atopic disease show that children are more likely to inherit these disorders if the mother is affected (parent-of-origin effect) [10]. The predominance of maternal inheritance may be due to environmental factors such as uterine milieu or breast feeding, but they may also arise due to genetic mechanisms such as parent-specific gene expression (genomic imprinting) [11].
###end p 9
###begin p 10
AD and atopic disorders are regarded as multifactorial conditions, the onset and severity of which are influenced by both genetic and environmental factors. The data are consistent with an immune etiology shared by all allergic diseases and a congenital target organ defect, the penetrance of which is modified by multiple environmental factors during early childhood. The identification of genes underlying AD and allergic disorders has the capacity to define primary physiologic mechanisms, thereby clarifying disease pathogenesis, identifying pathways and targets for therapeutic intervention.
###end p 10
###begin p 11
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b012">12</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b014">14</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b015">15</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
Although several genome-wide linkage screens for AD have been conducted [12-14], there was no substantial overlap between the identified regions of highest linkage, and the underlying genes remained elusive [15]. We have previously mapped a major susceptibility locus for AD on Chromosome 3q21 [16]. Here we report the identification and characterization of a novel epidermal collagen gene as the underlying disease gene.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 94 102 94 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g001">Figure 1</xref>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g001">Figure 1</xref>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-st001">Table S1</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b017">17</xref>
###xml 852 853 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 879 880 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 937 945 937 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-st001">Table S1</xref>
###xml 950 958 950 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g001">Figure 1</xref>
###xml 1186 1193 1186 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050242-t001">Table 1</xref>
###xml 1271 1272 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1272 1275 1272 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 1286 1287 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1287 1295 1287 1295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal</sub>
###xml 1552 1555 1552 1555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 1578 1581 1578 1581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 1593 1594 1593 1594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1594 1597 1594 1597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 1609 1612 1609 1612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mat</sub>
###xml 1615 1618 1615 1618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mat</sub>
###xml 1629 1630 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1630 1638 1630 1638 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal</sub>
###xml 1898 1910 1898 1910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal emp</sub>
###xml 1921 1923 1921 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b018">18</xref>
###xml 1120 1128 <span type="species:ncbi:9606">children</span>
To narrow the candidate region spanning 12.75 centiMorgans (cM) (13.5 Mb) on Chromosome 3q21 (Figure 1A), 96 additional microsatellite markers at an average distance of 140 kb were genotyped in 199 affected sibling families with AD from the original linkage scan. Linkage analysis yielded a 1-lod support interval of 5.4 Mb between the markers M3CS075 and M3CS233 (Figure 1B). Subsequently, we conducted an association scan of the 5.4-Mb region using 212 single nucleotide polymorphisms (SNPs) at an average distance of 25.5 kb (Table S1). The SNPs were selected primarily to cover known and predicted genes. Because we had observed a strong maternal effect in the linkage study [16], we chose a family-based association analysis that allowed us to search for risk alleles preferentially transmitted from the mother [17]. Two adjacent SNPs, rs5852593 (p = 0.0079) and rs1497309 (p = 0.016), located 36 kb apart, were associated with AD (Table S1 and Figure 1B). To define the critical region, we typed 16 additional SNPs. Eight of these markers showed association with AD and a maternal transmission pattern to affected children, which was consistent with our previous linkage results (Table 1). The strongest association with a single marker was observed for rs4688761 (pall = 0.0016, pmaternal = 0.0006). We selected eight markers spanning 96 kb that were associated with AD and carried nonredundant information based on the linkage disequilibrium (LD) in the region, and we performed haplotype analysis which confirmed the results (transmissions (T)all:non-transmissions (NT)all = 222:168, pall = 0.0076, Tmat:NTmat = 105:68, pmaternal = 0.0070). In addition, we assessed the significance of the difference in maternal-versus-paternal haplotype over transmissions empirically using the permutation procedure for parent-of-origin transmission disequilibrium test (TDT) implemented in PLINK (P_POOmaternal emp = 0.014) [18].
###end p 13
###begin title 14
Positional Cloning Strategy for the AD Disease Gene on Chromosome 3q21
###end title 14
###begin p 15
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D3S1303</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D3S1292</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 102 112 102 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GENEHUNTER</italic>
###xml 128 131 128 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
(A) The candidate region spanned 12.75 cM between markers D3S1303 and D3S1292. The y-axis depicts the GENEHUNTER nonparametric Zall as previously reported [16].
###end p 15
###begin p 16
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M3CS075</italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M3CS233</italic>
(B) Fine mapping with 96 microsatellite markers narrowed the interval to 5.4 Mb between markers M3CS075 and M3CS233. An association scan using 212 SNPs of the region revealed association of AD with two adjacent SNPs, rs5852593 and rs1497309. Genotyping of 16 additional SNPs refined the associated region.
###end p 16
###begin p 17
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
(C) Genomic positions of the 42 exons of COL29A1 are shown. The gene entirely encompasses the associated region.
###end p 17
###begin p 18
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
(D) The COL29A1 mRNA consists of 9226 bp. Translation start site and stop codon are indicated.
###end p 18
###begin p 19
(E) The predicted open reading frame encodes a protein of 2614 amino acids including a secretion peptide (SP), six N-terminal and three C-terminal vWAs, flanking a short collagen triple helix.
###end p 19
###begin p 20
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Results of the ASPEX sib_TDT for SNPs in the Region of COL29A1 for AD in the Discovery Cohort
###end p 20
###begin p 21
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 420 423 420 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 794 795 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 795 798 795 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
###xml 900 901 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 901 904 901 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all</sub>
Next, we investigated whether the observed association accounted for the linkage in the region. We used the marker that had shown the strongest association, rs4688761, to identify 73 of the 199 families from the original linkage scan in whom the disease-associated allele had been transmitted to affected offspring. Nonparametric linkage analysis in the 73 associated families yielded significant evidence for linkage (Zall = 4.18 versus 4.31 in the complete cohort), demonstrating that the majority of the linkage signal was attributable to these families. The significance of this finding was assessed by performing nonparametric linkage analysis in 10,000 random selections of 73 families. An empirical significance level was calculated as the proportion of replicates for which the maximum Zall score was equal or greater than that obtained in the actual analysis. The probability of obtaining a Zall score of >/=4.18 by chance in a random selection of 73 families was estimated by 10,000 simulations to be 0.027.
###end p 21
###begin p 22
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050242-t002">Table 2</xref>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050242-t003">Table 3</xref>
###xml 911 912 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 912 920 912 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal</sub>
###xml 945 957 945 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal emp</sub>
###xml 1072 1073 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1094 1095 1094 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1197 1199 1197 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 1249 1250 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1323 1324 1323 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1361 1362 1361 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1373 1375 1373 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1716 1717 1716 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1769 1770 1769 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1825 1826 1825 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1949 1950 1949 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 137 145 <span type="species:ncbi:9606">children</span>
To confirm the association result, we used a large independent replication set consisting of 292 complete nuclear families including 481 children with AD. We genotyped the selected eight SNPs covering an interval of 96 kb that were associated with AD in the discovery dataset. We confirmed the association with AD across all markers with the strongest association with AD observed for marker A36637742 (p = 0.00038), which also showed a significant overtransmission of the maternal allele (p = 0.0013) (Table 2). The association remained significant after correction for multiple testing. For each marker, it was the more common allele that was overtransmitted. Haplotypes were constructed over the region, which confirmed the association with AD and showed that this phenotype is associated with the overtransmission of the most common haplotype (haplotype frequency 65%, Table 3), and of the maternal allele (pmaternal = 0.000025 for AD, P_POOmaternal emp = 0.033). Next, we compared the AD status among the parents: in the discovery cohort, significantly more mothers (n = 63) than fathers (n = 19) suffered from AD (odds ratio [OR] 4.39, 95% confidence interval [CI] 2.51 - 7.68, p = 5.46 x 10-8). Similarly, in the replication cohort, mothers (n = 83) were significantly more frequently affected with AD than fathers (n = 55) (OR 1.71, 95% CI 1.16 - 2.52, p = 8.3 x 10-3). To assess whether the parent-of-origin effect that was observed originated from the discrepancy in AD prevalence among the parents, we compared haplotype transmissions from affected and unaffected mothers. In the discovery cohort, the excess in maternal transmissions was not predominantly attributable to affected mothers (T:UT = 24:21, p = 0.14) compared to unaffected ones (T:UT = 81:47, p = 0.0059). Similarly, affected mothers (T:UT = 25:17, p = 0.14) of the replication cohort did not contribute a larger transmission excess than the unaffected ones (T:UT = 70:29, p = 0.00013). We conclude that the observed maternal overtransmission pattern in both cohorts was not due to the higher AD prevalence among mothers.
###end p 22
###begin p 23
Association Analysis of Single Markers for Atopic Dermatitis in the Replication Dataset
###end p 23
###begin p 24
Haplotype Analysis for AD in the Replication Dataset
###end p 24
###begin p 25
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ35880</italic>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g001">Figure 1</xref>
###xml 572 580 572 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ35880</italic>
###xml 821 829 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g002">Figure 2</xref>
###xml 863 872 863 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC440978</italic>
###xml 877 887 877 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC131873,</italic>
###xml 1019 1028 1019 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-sg001">Figure S1</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b019">19</xref>
###xml 1116 1124 1116 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ35880</italic>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 1183 1188 <span type="species:ncbi:9606">human</span>
A database search within the associated 96-kb interval revealed a single predicted gene, FLJ35880, extending 11.6 kb into the associated region. No other expressed sequence tag was detected. To identify any additional transcripts, we used putative exons predicted with The National Center for Biotechnology Information (NCBI) Modelmaker within and bordering the critical region to perform rapid amplification of cDNA ends (RACE) from human skin mRNA. We thus identified a single transcript of 9226 bp that consisted of 42 exons (Figure 1D) and included all eight exons of FLJ35880. The corresponding gene spanned 139 kb of genomic sequence and completely encompassed the associated region. Pairwise LD measures (D') of the genotyped markers indicated that the gene was contained within one 170-kb region of increased LD (Figure 2), whereas the neighboring genes, LOC440978 and LOC131873, were located in separate blocks. The LD structure was consistent with the data for the European population in the HapMap database (Figure S1) [19]. The size of the transcript was confirmed by Northern blot hybridization with an FLJ35880-specific probe detecting a single transcript of 9.6 kb in human skin mRNA (unpublished data), which was in good agreement with the RACE experiments.
###end p 25
###begin title 26
Pairwise LD Values (D') Between 28 SNPs Based on Genotypes of the Founders in the Discovery Cohort
###end title 26
###begin p 27
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Boxes contain the LD values (D') between the respective markers indicated on top. Higher LD values correspond to a darker shade of red. Positions on Chromosome 3 are given in Mb; 131.547 denotes the start and 131.686 the end of COL29A1 on the genomic sequence. Boxes on the horizontal bar represent the 42 exons of COL29A1.
###end p 27
###begin p 28
###xml 598 606 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g001">Figure 1</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b020">20</xref>
###xml 877 885 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-st002">Table S2</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b021">21</xref>
###xml 1462 1469 1462 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COLVIA1</italic>
###xml 1545 1547 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b022">22</xref>
###xml 2025 2033 2025 2033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-st002">Table S2</xref>
###xml 300 305 <span type="species:ncbi:9606">human</span>
###xml 704 712 <span type="species:ncbi:9606">children</span>
###xml 1243 1248 <span type="species:ncbi:9606">human</span>
The open reading frame yielded a protein of 2614 amino acids with an estimated molecular weight of 289.9 kDa. The predicted protein contained a collagenous domain in the central part and was therefore classified as a new member of the collagen superfamily, collagen XXIX. A BLAST search revealed the human collagen VI alpha 3 chain as its closest neighbor (32% identity). Homology with collagen VI alpha 3 was further strengthened by a similar domain architecture consisting of six N-terminal and three C-terminal von Willebrand factor-type A domains (vWAs) flanking a short collagen triple helix (Figure 1E), and an 18-amino acid secretion signal [20]. Sequence analysis of all 42 exons in 46 unrelated children with AD and 2 unaffected individuals revealed 13 common and six rare sequence variations (frequency <2%) predicted to cause nonsynonymous amino acid substitutions (Table S2). Four variants were located within the triple helix repeat of a collagen domain, however none of them changed the first glycine residue in the repeating sequence patterns (Gly-X-Y), which is critical for triple helix formation [21]. In addition, we performed in silico comparisons of the six variants located within a vWA with the crystal structure of the human vWF A3 domain. One variant, V669G, affects an amino acid within a highly conserved stretch of eight amino acids. The mutation of an adjacent amino acid within this conserved region of a vWA in the homologous gene COLVIA1 has been reported to cause the monogenic muscle disorder Bethlem myopathy [22]. This variant, however was rare (allele frequency 1,3%). One additional variant (E455K) is located in a region predicted to be important for integrin-collagen interaction, and another one (M56T) is located in a helix near a rather conserved region that may also affect protein-protein interaction. All coding SNPs were genotyped in the discovery cohort. Four of them showed a positive association with AD that did, however, not account for the observed haplotype association (Table S2).
###end p 28
###begin p 29
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 207 215 207 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g003">Figure 3</xref>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
Gene expression analysis in human tissues revealed a tissue-specific expression pattern of COL29A1. The highest expression was observed in the skin, but also in the lung, small intestine, colon, and testis (Figure 3A). Overall, COL29A1 expression is moderately low compared to more abundant epidermal transcripts such as keratin 10 (unpublished data).
###end p 29
###begin title 30
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Gene Expression Analysis of COL29A1
###end title 30
###begin p 31
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 292 299 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 501 508 <span type="species:ncbi:9606">patient</span>
###xml 522 527 <span type="species:ncbi:9606">human</span>
(A) RT-PCR analysis of collagen XXIX in human tissues. (B) In situ gene expression analysis of COL29A1 in AD skin. In situ hybridization results of a COL29A1-specific antisense probe on cryostat sections (5 mum thick) of an AD skin biopsy (left) and a normal human control (right) are shown. COL29A1 mRNA detected by the digoxigenin-labelled probe is stained in blue (BCIP/NBT staining). The arrows point the different gene expression in the upper spinous and granular layer of the epidermis of an AD patient and a normal human control. Stratum basale (SB), stratum spinosum (SS), stratum granulosum (SG), and stratum corneum (SC) are indicated.
###end p 31
###begin p 32
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 541 549 541 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g003">Figure 3</xref>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-sg002">Figure S2</xref>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 727 728 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 947 954 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
###xml 645 653 <span type="species:ncbi:9606">patients</span>
###xml 717 725 <span type="species:ncbi:9606">patients</span>
###xml 880 888 <span type="species:ncbi:9606">patients</span>
To specify the expression sites in the layers of the skin and to assess the role of collagen XXIX in AD, we performed in situ hybridization using a COL29A1-specific cRNA-probe on skin biopsies of five patients with AD and five healthy patients (controls). In normal skin, COL29A1 was exclusively expressed in the epidermis with the strongest staining in the suprabasal viable layers. In contrast, the skin of patients with AD revealed a striking absence of COL29A1 mRNA staining in the most differentiated upper spinous and granular layers (Figure 3B and Figure S2). No significant difference in the expression of COL29A1 was observed comparing patients with AD to controls (1.28- +/- 0.53-fold down-regulation in AD patients, p = 0.41) using quantitative Taqman reverse-transcriptase (RT)-PCR. These results indicate that while differences in mRNA quantity were not detected, AD patients show a distinct abnormal cellular distribution pattern of COL29A1 expression in the differentiated outer epidermis.
###end p 32
###begin p 33
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050242-g004">Figure 4</xref>
###xml 494 503 494 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050242-sg003">Figure S3</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
We generated a polyclonal antibody to visualize the collagen XXIX protein in the skin of five patients with AD and five normal controls, including four and three of each group, respectively, in whom in situ analysis was performed. Consistent with the in situ findings, we observed collagen XXIX staining in the differentiated suprabasal layers of the epidermis in normal human skin and a remarkable absence of staining in the most differentiated upper spinous and granular layers (Figure 4 and Figure S3).
###end p 33
###begin title 34
Immunohistochemical Analysis of Collagen XXIX Expression in AD Skin
###end title 34
###begin p 35
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
Cryostat sections (5mum thick) of an AD skin biopsy (A) and a normal human control (B) are shown. In normal, human skin, collagen XXIX is expressed in the epidermis. In patients with atopic dermatitis, a striking lack of collagen XXIX staining was observed in the viable outermost spinous and granular layers of the epidermis (arrow). Stratum basale (SB), stratum spinosum (SS), stratum granulosum (SG), and stratum corneum (SC) are indicated. Collagen XXIX was stained with fuchsin (red). Sections were counterstained with hematoxylin (blue).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b013">13</xref>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1,</italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
In a whole-genome linkage scan for AD, we previously identified a susceptibility locus on human Chromosome 3q21. The candidacy of this chromosomal region was further supported by Bradley et al., who mapped a locus for AD severity in close proximity (3q14) in a Swedish population [13]. By positional cloning, we have now identified the disease-causing gene, COL29A1, which encodes a novel epidermal collagen.
###end p 37
###begin p 38
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 847 854 847 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 979 986 979 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1211 1218 1211 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
###xml 1360 1367 1360 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
The disease gene was located in a two-staged investigation consisting of systematic linkage and association scanning of the region and subsequent confirmation of the association in a large, independent, replication dataset. In the first stage, we genotyped additional microsatellite markers in the candidate region, which narrowed the initial 12.75-cM linkage interval to 5.4 Mb. The association analysis with an average marker distance of 25.5 kb, finally, revealed an association that was confined to a haplotype block of 170 kb, which included a single gene, COL29A1. Pairwise LD measures indicated LD across the entire gene and defined two subblocks of increased LD. The strongest association was observed within the 96-kb subblock encoding the collagenous domain and the C terminus of collagen XXIX. A rapid decay of LD at the borders of the COL29A1 haplotype block and lack of association of the SNPs located within the neighboring genes clearly limited the association to COL29A1. In addition, we demonstrated in the discovery dataset that the families that contributed to the association of SNP rs4688761 with AD also accounted for most of the linkage signal. This finding corroborated that variants in COL29A1 explained the previously reported linkage of AD to 3q21 [16]. Finally, we confirmed association in a large independent family cohort, making COL29A1 the first AD susceptibility gene, to our knowledge, that is identified by positional cloning.
###end p 38
###begin p 39
###xml 473 480 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b023">23</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b024">24</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b025">25</xref>
###xml 1260 1267 1260 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 188 196 <span type="species:ncbi:9606">children</span>
###xml 1153 1158 <span type="species:ncbi:10090">mouse</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
###xml 1433 1438 <span type="species:ncbi:9606">child</span>
Consistent with the linkage analysis, we found a maternal transmission pattern to affected offspring in both family cohorts. Although the sexes were equally represented among the affected children of both cohorts, we observed a marked maternal preponderance in AD status among the parents in both cohorts. This finding clearly supports the notion of a maternal effect. It may, however, also raise the question whether the maternal overtransmission pattern observed for the COL29A1 haplotype was due to the different prevalence of AD in mothers and fathers. This is unlikely to be the case, because the analytical tools used in this study, nonparametric linkage and TDT, do not take into account the parental phenotype. Furthermore, we showed that the observed maternal effect was not predominantly attributable to transmissions from affected rather than unaffected mothers. Although parent-of-origin effects have not previously been reported for genes from Chromosome 3q21, they have been observed at other loci influencing allergic disease [23]. Tissue-specific imprinting of genes encoding extracellular matrix (ECM) proteins has been reported in the mouse [24], and their disruption has been shown to impair skin structure and function [25]. Interestingly, COL29A1 is expressed in human placenta, an organ of embryonic origin. Apart from classic genomic imprinting mechanisms, maternal effects may be due to an interaction of the child's genotype with the maternal environment during prenatal life.
###end p 39
###begin p 40
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b026">26</xref>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Sequencing of the exons and promoter region revealed 19 nonsynonymous coding SNPs, six of which were located within a vWA. In silico analysis of these variants revealed only one rare mutation altering a highly conserved amino acid, but all of them may affect protein-protein interaction. None of the nonsynonymous coding SNPs explained the observed association on its own. It has been demonstrated in other complex diseases that multiple independent variants may occur in a single disease gene [26]. It is therefore possible that several variants or combinations thereof which are associated with the most common haplotype of COL29A1 are involved in the disease pathogenesis. The functional influence of the associated variants remains to be determined.
###end p 40
###begin p 41
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b027">27</xref>
###xml 389 396 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b028">28</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b029">29</xref>
Involvement of COL29A1 in AD is further supported by its tissue- and cell-specific expression pattern. Like COL29A1, a growing number of collagens recently identified show a restricted expression pattern. These are not mainly found in fibrous connective tissue, but rather in the ECM of more specialized tissue structures pointing to a distinctive function of these proteins [27]. Highest COL29A1 expression was observed in the skin, but also in other epithelial tissues such as the lung, small intestine, and colon, which are the main manifestation sites of allergic disorders, including asthma and food allergies. This gene expression pattern might indicate a role of collagen XXIX in a wider spectrum of allergic diseases and suggests a molecular link between AD, respiratory airways disease, and food allergies, which are epidemiologically closely associated [28,29].
###end p 41
###begin p 42
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 515 517 515 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b030">30</xref>
###xml 770 777 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 273 281 <span type="species:ncbi:9606">patients</span>
In human skin, collagen XXIX was detected throughout the viable layers of the epidermis with an increase toward the differentiated cells of the granular layer. Comparative expression analysis of COL29A1 by in situ hybridization and immunohistochemistry in skin biopsies of patients with AD and healthy controls revealed a distinct lack of COL29A1 mRNA and protein in the outer viable layers of the epidermis. The process of epidermal stratification is tightly regulated by an increasing gradient of extracellular Ca2+ concentration and a specific special and temporal expression pattern of transcriptional regulators [30]. Our findings indicate that the specific cellular milieu acquired during terminal epidermal differentiation affect the regulation or degradation of COL29A1 mRNA in the outer epidermis. However, our findings do not allow us to distinguish between these two processes.
###end p 42
###begin p 43
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b031">31</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b032">32</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b033">33</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b034">34</xref>
###xml 1048 1054 1048 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A</italic>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b035">35</xref>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b036">36</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b037">37</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 1115 1123 <span type="species:ncbi:9606">patients</span>
Lack of collagen XXIX in the outer epidermis of AD patients indicates that a defective ECM may give rise to the disease, proposing a new pathomechanism for AD. Collagens are the most abundant ECM proteins in vertebrates and play a crucial role in maintaining tissue integrity. Their importance for tissue function has been highlighted by the wide spectrum of human diseases caused by mutations in collagen genes [31]. Although a large number of collagens in the connective tissue-rich dermis have been characterized, little is known about collagens in the ECM of the epidermis [32,33]. Collagen XXIX belongs to the vWA containing collagens. They form filaments with globular domains containing the vWA motifs, which are involved in protein-ligand interactions for the organization of tissue architecture and cell adhesion [34]. It is therefore conceivable that collagen XXIX plays an important role in keratinocyte cohesion. Lack of collagen XXIX may facilitate antigen penetration through the skin, which may explain the association found between COL29A variants and allergic sensitization, a common feature in AD patients [35]. Recent findings indicate that structural and functional integrity of the epidermis is a key factor in the development of AD [36] and in the disease progression to allergic airways disease [37].
###end p 43
###begin p 44
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b038">38</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b039">39</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b040">40</xref>
###xml 604 625 604 625 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b041">41</xref>
###xml 486 494 <span type="species:ncbi:9606">Patients</span>
###xml 604 625 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
Furthermore, ECM collagens influence the migration of epidermal antigen-presenting Langerhans cells and T cells [38,39] and may thus play an important role in the initiation and maintenance of cutaneous immune responses. In addition, ECM collagens participate in immune regulation by binding to inhibitory immune receptors [40], rendering collagen XXIX an interesting novel susceptibility gene for AD. Impairment of the immune defense function of the skin is a clinical hallmark of AD. Patients with AD show a diminished resistance against microbes resulting in the colonization of nonlesional skin with Staphylococcus aureus in nearly 90% of patients and an increased susceptibility to bacterial and viral skin infections [41]. Our findings led to the identification of collagen XXIX as a novel component of the epidermal ECM and propose a new disease mechanism in the etiology of atopic dermatitis and allergies.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects.
###end title 46
###begin p 47
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
The diagnosis of AD was made according to standard criteria, as previously described [16]. Recruitment was restricted to patients with an age of onset below 2 y and moderate to severe disease expression. Total IgE levels and levels of specific IgE against 12 common environmental allergens were determined using ImmunoCAP (Phadia AB; ). Allergic sensitization was defined as either the presence of specific IgE to at least one allergen (detection limit 0.35 kU/l) or a total serum IgE level elevated above the age-specific norm. The institutional review boards of the participating centers approved the study protocol and informed consent was obtained from all probands or their legal guardians.
###end p 47
###begin p 48
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
###xml 202 210 <span type="species:ncbi:9606">children</span>
###xml 331 339 <span type="species:ncbi:9606">children</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 501 505 <span type="species:ncbi:9606">boys</span>
###xml 547 555 <span type="species:ncbi:9606">children</span>
One discovery study sample and one replication sample were investigated. All families were of European origin. The discovery data set consisted of 199 complete affected sibling families composed of 427 children with AD that were studied in the original genome scan. [16] The replication set consisted of 292 families including 481 children with AD with an age of onset </=2 y and moderate to severe disease expression. Among AD patients in the discovery and the replication cohorts, the proportion of boys was 52% and 50.9%, and the proportion of children with allergic sensitization was 74% and 72.1%, respectively.
###end p 48
###begin p 49
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Punch biopsies of human skin were obtained from six patients with AD and 7 healthy donors aged 24-55 y with written informed consent. Specimens were prepared for in situ hybridization and immunohistochemistry as described below.
###end p 49
###begin title 50
Microsatellite genotyping.
###end title 50
###begin p 51
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D3S1303</italic>
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D3S1292</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b016">16</xref>
###xml 300 305 <span type="species:ncbi:9606">human</span>
In the first stage, fine mapping with microsatellite markers was performed in the discovery dataset. 96 short tandem repeat markers were selected within the interval between D3S1303 (126.07 cM) and D3S1292 (138.82 cM) from the Genethon () and Marshfield () databases, or were identified by screening human genome sequence data for short tandem repeats. Fluorescence-based semi-automated genotyping was performed as previously described [16]. Primer sequences, amplification conditions, and allele size are available on request.
###end p 51
###begin title 52
Association scan with SNPs.
###end title 52
###begin p 53
###xml 600 608 <span type="species:ncbi:9606">patients</span>
We performed an association scan of the 5.4-Mb region using 212 SNPs at an average distance of 25.5 kb. The SNPs were selected from the NCBI database () to cover known and predicted genes. To determine the allele frequency of the polymorphisms, we amplified 600 to 800 bp surrounding each SNP by PCR for resequencing in 31 unrelated Caucasian individuals. Markers with a minor allele frequency (MAF) of >5% were selected for genotyping. To identify functional variants in collagen XXIX, we sequenced all 42 exons including the exon-intron boundaries and 5.1 kb of the promoter region in 46 unrelated patients with AD and two controls. Sequencing was performed on an ABI3730 DNA sequencer (Applied Biosystems; ) using standard procedures.
###end p 53
###begin p 54
We carried out SNP genotyping using TaqMan allelic discrimination, with probes and primers designed and synthesized by the supplier (Applied Biosystems), or by pyrosequencing using PSQ HS 96A (Pyrosequencing AB; ). The averages genotyping success rate was 97.9%. All primer and probe sequences are available on request.
###end p 54
###begin title 55
Statistical analysis.
###end title 55
###begin p 56
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b042">42</xref>
###xml 197 198 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
We performed linkage analysis of the microsatellite data using Genehunter V. 2.1 [42]. Each SNP was checked for compliance with Hardy-Weinberg equilibrium (HWE) in the parent population using a chi2 test, and those markers that were not in HWE were excluded from the analysis. We calculated pairwise LD between each marker pair using the D' statistic.
###end p 56
###begin p 57
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b017">17</xref>
###xml 477 479 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b018">18</xref>
In view of the strong imprinting effect at our locus, we conducted family-based association tests, because this strategy allows us to determine the parental origin of an associated allele. In the affected sibling families, we used the sib_TDT of the ASPEX software that performs a permutation procedure to calculate empirical p-values that are independent of linkage within families [17]. Furthermore, to assess the significance of the maternal effect, we calculated empirical p-values for the difference in maternal versus paternal haplotype transmissions using the parent-of-origin TDT implemented in PLINK [18].
###end p 57
###begin p 58
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b043">43</xref>
###xml 462 463 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 526 528 524 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 712 714 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b044">44</xref>
The sib_TDT was also used in the analysis of eight markers in the replication dataset. The significance level of the replication results was assessed empirically. Using all pedigrees and all genetic markers used in the actual analysis, we generated 10,000 replicates using Allegro V1.2c [43] and conducted an association analysis as in the original dataset. An empirical significance level was calculated as the proportion of replicates for which the maximum chi2 score was greater than that obtained in the real dataset. All p-values are two-sided, significance was defined as statistical evidence expected to occur 0.05 times at random in the analysis. For multipoint analysis, we used the FBAT tools package [44] to generate haplotypes and performed family-based association tests for five marker haplotypes using the empirical variance option to adjust for correlation among sibling genotypes. To evaluate parent-of-origin effects in the multipoint analysis, we estimated haplotypes using MERLIN, recoded the haplotypes as alleles, and performed the sib_TDT using ASPEX.
###end p 58
###begin title 59
In silico protein analysis.
###end title 59
###begin p 60
###xml 732 739 732 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 647 652 <span type="species:ncbi:9606">human</span>
Protein sequences were retrieved from the UniProt () and Ensembl () databases. The domain architecture of the collagen XXIX protein was retrieved from the NCBI conserved domain search website (). The following domains were found in collagen XXIX and analyzed further: cd01472 (vWA_collagen), cd01450 (vWFA_subfamily_ECM), cd01470 (vWA_complement_factors), cd01465 (vWA_subgroup), and Pfam01391 (collagen triple helix repeat). To predict the 3D structure of the vWF protein domains in collagen XXIX, we explored the structure prediction results returned by the web servers GenTHREADER () and FFAS03 (). Based on their very similar predictions, the human vWF A3 domain was chosen as the structural template to analyze the position of COL29A1 SNPs in 3D and to predict their potential effect on protein function.
###end p 60
###begin title 61
Exon identification and characterization of the collagen XXIX gene.
###end title 61
###begin p 62
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 514 521 514 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b045">45</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b046">46</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 355 360 <span type="species:ncbi:9606">human</span>
A 2447-bp sequence from a human testis cDNA library which covered eight exons was the starting point for the characterization of COL29A1. Using rapid amplification of cDNA ends together with the Model Maker of NCBI, we identified a total of 42 exons and determined the transcription start site as well as the 3' end of the COL29A1 transcript in cDNA from human skin. The complete sequence of the transcript was confirmed by cloning and sequencing of the full-length cDNA. To explore the potential gene function of COL29A1, the protein sequence was predicted (), a domain search was performed () [45], and the presence and location of signalling peptides was analyzed () [46].
###end p 62
###begin title 63
Gene expression analysis.
###end title 63
###begin p 64
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 430 437 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
We examined tissue-specific expression of COL29A1 using oligo(dT)-primed cDNA of 17 different human tissues. cDNA samples of 16 tissues were from the human MTC Panels I and II, which are standardized for the expression of GAPDH (BD Biosciences; ). In addition, human skin poly(A)+ RNA (BD Biosciences) was transcribed into cDNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics; ). PCR was performed using COL29A1-specific primers 5'-GTTCTAACCAGAATGTATAATCATC (forward) and 5'-TAATTCCCAAGAACATCTCTGGT (reverse), yielding a product of 694 bp, and the GAPDH control primers supplied with the MTC panels.
###end p 64
###begin p 65
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
For in situ hybridization, we generated a plasmid by cloning a COL29A1-specific PCR product amplified from human skin cDNA [5'-ACCTTAGGAGACAGGGTTGCT (forward); 5'-AGTTCCAATCTGGCTTGTGG (reverse)] into the pCRII vector (Invitrogen; ). We synthesized antisense and sense digoxigenin-labeled riboprobes using the Dig RNA Labeling Kit (Roche Diagnostics). Punch biopsies of human skin were obtained from five AD patients and five healthy donors, immediately fixed in 4% paraformaldehyde for 4 h, cryoprotected in 30% sucrose overnight, and embedded in Tissue-Tek (Sakura; ) for cryosectioning. 10 mum cryosections were mounted on slides and dried for 15 min at 50 degreesC. Sections were postfixed in 4% paraformaldehyde for 7 min at 4 degreesC and acetylated with 0.25% acetic acid for 10 min. Sections were prehybridized for 3 h and hybridized overnight at 50 degreesC with digoxigenin-labeled riboprobes. After hybridization, sections were washed twice with 2 x SSC at 53 degreesC and once with 0.1 x SSC at 58 degreesC. For detection of the hybridized probe, slides were incubated with BCIP/NBT staining solution (Roche Diagnostics) for 4 d according to the manufacturer's recommendations.
###end p 65
###begin p 66
###xml 521 528 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 731 738 722 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 773 780 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 1184 1185 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
To quantify gene expression in skin specimens, total RNA was isolated from 160 mum cryosections of skin biopsies using the RNeasy Mini Kit (Qiagen; ). RNA was reverse transcribed into cDNA with random hexamer primers using the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics). Taqman real-time PCR was performed with iTaq SYBR Green (BioRad; ) and gene-specific PCR products were detected on the ABI PRISM 7900 sequence detection system (Applied Biosystems). All measurements were performed in duplicate. COL29A1 expression was normalized for 18S rRNA expression. Differences in gene expression were calculated using the DeltaDeltact method and were expressed as fold change. Gene-specific primers were as follows; COL29A1-forward, 5'-CCACCCTCTGGATCATCACT, COL29A1-reverse, 5'-GTTTTCTGTGCCACCGTTCT, KRT10-forward, 5'-CTGAAACCGAGTGCCAGAAT, KRT10-reverse, 5'-GCCTCCGGAACTTCCCTCT, 18S rRNA-forward, 5'-GGATGCGTGCATTTATCAGA, 18S rRNA-reverse, 5'-GATCAGCCCGAGGTTATCTA. The sizes of the PCR products were confirmed by gel electrophoresis and the specificity of the reaction was confirmed by melting curve analysis of the PCR products. For statistical analysis, the unpaired t-test was used.
###end p 66
###begin title 67
Antibodies and immunohistochemistry.
###end title 67
###begin p 68
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 83 90 <span type="species:ncbi:9986">rabbits</span>
A polyclonal antibody against human collagen XXIX protein was raised by immunizing rabbits with a collagen XXIX specific peptide (SLGSTRKDDMEELAC, residues 2115-2128) (Eurogentec; ). The specificity of the antibodies purified by affinity chromatography was tested by comparing their reactivity against recombinant proteins by Western blotting and by blocking experiments.
###end p 68
###begin p 69
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 300 306 <span type="species:ncbi:9986">rabbit</span>
###xml 631 638 <span type="species:ncbi:9986">rabbits</span>
###xml 734 742 <span type="species:ncbi:9606">patients</span>
For immunohistochemistry, freshly isolated skin specimens from five AD patients and five healthy individuals were embedded in Tissue-Tek. Cryosections of 5 mum thickness were prepared and fixed with acetone. Sections were incubated with anti-collagen XXIX antibodies followed by dextran-coupled anti-rabbit antibody, an alkaline phosphatase labelled amplification polymer (DAKO EnVision System; ) and detection with fuchsin (DAKO). Nuclei were counterstained with Mayer's hematoxylin solution (Sigma-Aldrich; ). Omission of primary antibody and preincubation with equimolar amount of peptide used for generation of the antibody in rabbits were used as negative controls for parallel sections. The results were consistent among the AD patients on one hand, and among the control biopsies on the other.
###end p 69
###begin title 70
Supporting Information
###end title 70
###begin title 71
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
Hapmap LD Data for the COL29A1 Region on Human Chromosome 3
###end title 71
###begin p 72
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050242-b019">19</xref>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 423 428 <span type="species:ncbi:9606">human</span>
LD plot for the CEPH population (Utah residents with ancestry from northern and western Europe) is shown [19]. The intensity of the color of the red boxes represents the pairwise LD values (r2) between two markers. Positions of the markers genotyped by the HapMap Project are indicated by vertical dashes on the horizontal bar. The scale indicates the physical position on Chromosome 3 in kb. Gene loci were taken from the human genome NCBI build 36.2 and correspond to the largest mRNA identified (FLJ35880 and LOC131873) or were predicted (LOC646300).
###end p 72
###begin p 73
(1.3 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin title 75
Gene Expression Analysis
###end title 75
###begin p 76
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 316 323 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 205 210 <span type="species:ncbi:9606">human</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
Gene expression analysis of COL29A1 in the epidermis of AD patients (A) and of non-affected individuals (B). Cryosections (5 mum thick) of skin biopsies of five AD patients (AD1 to AD5) and of five normal human control individuals (NC1 to NC5) were hybridized with a digoxigenin-labeled antisense probe specific for COL29A1 mRNA (on the left) and with a digoxigenin-labeled sense probe as a negative control (on the right). Staining of the detected transcripts was performed with the BCIP/NBT staining solution (blue). No staining was observed in the upper spinous and granular layer (indicated by arrows) of AD patients. The mRNA expression pattern was in good agreement with the results of the immunohistochemical staining of the protein. Sections were photographed at 200xmagnification (AD5, 100x).
###end p 76
###begin p 77
(15 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin title 79
Immunohistochemical Analysis
###end title 79
###begin p 80
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 296 302 <span type="species:ncbi:9986">rabbit</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
Immunohistochemical analysis of collagen XXIX expression in the epidermis of AD patients (A) and of non-affected individuals (B). Cryosections (5 mum thick) of skin biopsies of five AD patients (AD1-AD4, AD6) and of five normal human control individuals (NC1-NC3, NC6, NC7) were incubated with a rabbit polyclonal antibody against ColXXIX epitope and stained with fuchsin (red). Counterstaining was performed with hematoxylin (blue). Negative controls (on the right) were lacking the primary antibody. In normal, human skin, collagen XXIX is expressed in the epidermis with a slight increase towards the more differentiated layers. AD patients lack the protein in the upper spinous and granular layer as indicated by arrows. Sections were photographed at 200x magnification (AD5, 100x).
###end p 80
###begin p 81
(18 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin title 83
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M3CS075</italic>
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M3CS233</italic>
SNPs Used in the Association Scan in the 5.4-Mb Region Between Markers M3CS075 and M3CS233
###end title 83
###begin p 84
The average typing rate was >/= 97.9%
###end p 84
###begin p 85
(564 KB DOC)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin title 87
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Nonsynonymous Coding SNPs in COL29A1
###end title 87
###begin p 88
vWA, von Willebrand factor domain; Col, collagen domain
###end p 88
###begin p 89
(113 KB DOC)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin title 91
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL29A1</italic>
Results of the ASPEX sib_TDT for SNPs in the Region of COL29A1 for Allergic Sensitization in the Discovery Cohort
###end title 91
###begin p 92
(112 KB DOC)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin title 94
Association Analysis of Single Markers for Allergic Sensitization in the Replication Dataset
###end title 94
###begin p 95
(58 KB DOC)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin title 97
Haplotype Analysis for Allergic Sensitization in the Replication Dataset
###end title 97
###begin p 98
(49 KB DOC)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin title 100
Accession Numbers
###end title 100
###begin p 101
###xml 94 105 94 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(FLJ35880),</italic>
###xml 116 126 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(FLJ35880)</italic>
###xml 143 148 <span type="species:ncbi:9606">human</span>
The GenBank () accession numbers for genes and proteins discussed in this paper are: AK093199 (FLJ35880), NM 153264 (FLJ35880), and NP 476507 (human collagen VI alpha 3 chain),
###end p 101
###begin p 102
###xml 49 54 <span type="species:ncbi:9606">human</span>
The Protein Databank () accession number for the human vWF A3 domain is 1atz.
###end p 102
###begin p 103
###xml 13 21 <span type="species:ncbi:9606">patients</span>
We thank the patients with atopic dermatitis and their families for their participation; Monika Schwarz, Jenny Pech, Christina Flachmeier, and Sabine Enigk for technical assistance; and Dr. Sylke Schneider and Dr. Claudia Rasche for performing the skin biopsies.
###end p 103
###begin title 104
Abbreviations
###end title 104
###begin p 105
atopic dermatitis
###end p 105
###begin p 106
centiMorgan
###end p 106
###begin p 107
collagen XXIX gene
###end p 107
###begin p 108
extracellular matrix
###end p 108
###begin p 109
linkage disequilibrium
###end p 109
###begin p 110
reverse-transcriptase PCR
###end p 110
###begin p 111
single nucleotide polymorphism
###end p 111
###begin p 112
von Willebrand factor-type A domain
###end p 112
###begin title 113
References
###end title 113
###begin article-title 114
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
###end article-title 114
###begin article-title 115
The prevalence of childhood atopic eczema in a general population
###end article-title 115
###begin article-title 116
Changes in the reported prevalence of childhood eczema since the 1939-45 war
###end article-title 116
###begin article-title 117
Prurigo Besnier (atopic dermatitis) with special reference to the role of allergic factors
###end article-title 117
###begin article-title 118
What drives the allergic march?
###end article-title 118
###begin article-title 119
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human sensitization
###end article-title 119
###begin article-title 120
Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study
###end article-title 120
###begin article-title 121
Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample
###end article-title 121
###begin article-title 122
Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample
###end article-title 122
###begin article-title 123
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
###end article-title 123
###begin article-title 124
What good is genomic imprinting: The function of parent-specific gene expression
###end article-title 124
###begin article-title 125
Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci
###end article-title 125
###begin article-title 126
Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population
###end article-title 126
###begin article-title 127
Atopic dermatitis-a total genome-scan for susceptibility genes
###end article-title 127
###begin article-title 128
The genetics of atopic dermatitis
###end article-title 128
###begin article-title 129
A major susceptibility locus for atopic dermatitis maps to chromosome 3q21
###end article-title 129
###begin article-title 130
PLINK: A tool set for whole genome association and population-based linkage analyses
###end article-title 130
###begin article-title 131
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 131
###begin article-title 132
Improved prediction of signal peptides: SignalP 3.0
###end article-title 132
###begin article-title 133
Prediction of collagen stability from amino acid sequence
###end article-title 133
###begin article-title 134
Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy
###end article-title 134
###begin article-title 135
Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor
###end article-title 135
###begin article-title 136
Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray
###end article-title 136
###begin article-title 137
Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility
###end article-title 137
###begin article-title 138
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
###end article-title 138
###begin article-title 139
The immunogenetics of asthma and eczema: A new focus on the epithelium
###end article-title 139
###begin article-title 140
Atopic dermatitis and the atopic march
###end article-title 140
###begin article-title 141
Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
###end article-title 141
###begin article-title 142
Mechanisms regulating epithelial stratification
###end article-title 142
###begin article-title 143
###xml 52 58 <span type="species:ncbi:9606">humans</span>
Collagens, modifying enzymes and their mutations in humans, flies and worms
###end article-title 143
###begin article-title 144
Allergy in 7000 twin pairs
###end article-title 144
###begin article-title 145
Expression of type XXIII collagen mRNA and protein
###end article-title 145
###begin article-title 146
Distribution and evolution of von Willebrand/integrin A domains: Widely dispersed domains with roles in cell adhesion and elsewhere
###end article-title 146
###begin article-title 147
New insights into atopic dermatitis
###end article-title 147
###begin article-title 148
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
###end article-title 148
###begin article-title 149
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march
###end article-title 149
###begin article-title 150
Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines
###end article-title 150
###begin article-title 151
Reprogramming T cells: The role of extracellular matrix in coordination of T cell activation and migration
###end article-title 151
###begin article-title 152
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1
###end article-title 152
###begin article-title 153
###xml 66 87 66 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 66 87 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema
###end article-title 153
###begin article-title 154
Parametric and nonparametric linkage analysis: A unified multipoint approach
###end article-title 154
###begin article-title 155
Allegro, a new computer program for multipoint linkage analysis
###end article-title 155
###begin article-title 156
Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics
###end article-title 156
###begin article-title 157
The Pfam protein families database
###end article-title 157
###begin article-title 158
Predicting subcellular localization of proteins based on their N-terminal amino acid sequence
###end article-title 158
###begin p 159
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 330 335 <span type="species:ncbi:9606">human</span>
Author contributions. YAL designed the experiments and directed the study. CS, IM, TK, JEG, and NH performed the experiments. FR, KR, and HS performed the statistical analyses. GM and MA performed the in silico protein analysis. CG, UW, MW, and YAL were responsible for family recruitment, clinical phenotyping, and taking of the human skin biopsies. CS, IM, NH, and YAL wrote the paper.
###end p 159
###begin p 160
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by grants from the German Ministry for Education and Research through the Clinical Research Group for Allergy and the German National Genome Research Network "Environmental Diseases" and the "DNA Platform" to YAL and NH. Jorge Esparza-Gordillo is supported by an EMBO long-term fellowship (LTF 522-2006).
###end p 160
###begin p 161
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 161

